Agenda: Next Multiplex Genomic Testing in Liquid Biopsy - From Discovery to Applications - Digital Engager

11:00 am Welcome to Stilla Technologies Engager

  • Matthew Grow Vice President, Global Marketing & Commercial Operations, Stilla Technologies

11:05 am Panel Discussion & Q&A: Next Generation Multiplex Genomic Testing in Liquid Biopsy – From Discovery to Applications

  • Matthew Grow Vice President, Global Marketing & Commercial Operations, Stilla Technologies
  • Phillipe Mourere President & Chief Executive Officer, Stilla Technologies
  • Steven Rosen Scientific Innovation Leader in Healthcare, Wyss Institute, Harvard University
  • Sean Downing Senior Director, Clinical Biomarkers & Head of Molecular Pathology, Genomics & CDx,

Synopsis

• Examine the accessibility and democratization of dPCR multiplexing across labs in the LBx space
• Learn how multiplexed dPCR can help you take the next step from NGS to routine testing
• Evaluate current evidence on innovative technologies to improve detection, prognosis, disease monitoring, and drug development

11:50 am Open Interactive Discussion

Synopsis

Engage, converse and strengthen your connections with the most influential technology providers in the industry

12:30 pm End of Stilla Technologies Engager